Intellipharmaceutics International, Inc.(Toronto Stock Exchange : IPCI)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VTL | Vital Therapies, Inc. | 1.50% | 13.51 | 3.3% | $792.68m | |
| AMGN | Amgen Inc. | 0.97% | 206.00 | 1.3% | $773.44m | |
| GILD | Gilead Sciences, Inc. | 1.54% | 64.11 | 0.9% | $388.34m | |
| CELG | Celgene Corporation | 0.51% | 95.22 | 1.3% | $348.72m | |
| BIIB | Biogen Inc. | 1.74% | 235.72 | 1.3% | $309.32m | |
| ILMN | Illumina, Inc. | 0.87% | 288.65 | 3.5% | $303.84m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.16% | 187.09 | 1.9% | $267.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.65% | 112.68 | 2.0% | $250.97m | |
| EXAS | Exact Sciences Corporation | -1.39% | 118.16 | 24.1% | $248.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.52% | 298.38 | 2.6% | $217.05m | |
| A | Agilent Technologies, Inc. | 0.96% | 71.76 | 1.6% | $206.55m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.71% | 120.31 | 14.7% | $153.85m | |
| INCY | Incyte Corporation | 1.68% | 84.52 | 2.5% | $100.26m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.19% | 77.41 | 4.3% | $94.71m | |
| GHDX | Genomic Health, Inc. | -0.56% | 74.22 | 1.8% | $90.42m |
Company Profile
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.